Small extracellular vesicles derived from synovial fibroblasts contain distinct miRNA profiles and contribute to chondrocyte damage in osteoarthritis.
滑膜線維芽細胞由来の小型細胞外小胞は特徴的なmiRNAプロファイルを含み、変形性関節症における軟骨細胞障害に寄与する (機械翻訳の邦題)
記録の確認項目
- 研究デザイン
- その他の原著論文
- 対象
- ヒト
- 出版年
- 2024
- 出典
- doi.org
- 抄録の表示
- 表示あり
- 出版状態
- 有効な記録
- 状態確認日
- 2026/08/17
- 収集日
- 2026/08/04
- 鮮度
- 確認期限内
- 確認段階
- 自動処理
- 記録状態
- 公開
日本語要約(機械生成)
変形性関節症(OA)患者の滑膜線維芽細胞(SF)由来の小型細胞外小胞(sEV)が、軟骨細胞の炎症・リモデリング応答を調節するかを検討した。OA滑膜と軟骨からSFと軟骨細胞を分離し、sEVを超遠心法で単離・特性評価した。sEVは軟骨細胞に取り込まれ、MMP13遺伝子発現を増加させ、アグリカンとCOL2A1の発現を減少させた。IL-1β刺激SF由来sEVはアグリカンとCOL2A1の発現をさらに減少させ、SOX9発現を増加させた。また、sEVはIL-6、IL-8、MMP-3の分泌を増加させ、軟骨外植片のsGAG放出を増加させた。miRNA解析では、sEVは親細胞と異なるプロファイルを示し、miR182などが濃縮されていた。IL-1β刺激によるプロファイル変化は認められなかった。OA SF由来sEVは軟骨細胞の炎症と分解を促進し、新規治療標的となる可能性が示唆された。
この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。
抄録
Background: Small extracellular vesicles (sEV) derived from synovial fibroblasts (SF) represent a novel molecular mechanism regulating cartilage erosion in osteoarthritis (OA). However, a comprehensive evaluation using disease relevant cells has not been undertaken. The aim of this study was to isolate and characterise sEV from OA SF and to look at their ability to regulate OA chondrocyte effector responses relevant to disease. Profiling of micro (mi) RNA signatures in sEV and parental OA SF cells was performed.Methods: SF and chondrocytes were isolated from OA synovial membrane and cartilage respectively (n = 9). sEV were isolated from OA SF (± IL-1β) conditioned media by ultracentrifugation and characterised using scanning electron microscopy (SEM) and transmission electron microscopy (TEM). Particle size was confirmed by nanoparticle tracking analysis (NTA). sEV regulation of OA chondrocyte and cartilage effector response was evaluated using qPCR, ELISA and sulphated glycosaminoglycan assay (sGAG). RNA-sequencing was used to establish miRNA signatures in isolated sEV from OA SF.Results: OA SF derived sEV were readily taken up by OA chondrocytes, with increased expression of the catabolic gene MMP 13 (p < 0.01) and decreased expression of the anabolic genes aggrecan and COL2A1 (p < 0.01) observed. Treatment with sEV derived from IL-1β stimulated OA SF significantly decreased expression of aggrecan and COL2A1 (p < 0.001) and increased SOX 9 gene expression (p < 0.05). OA chondrocytes cultured with sEV from either non-stimulated or IL-1β treated OA SF, resulted in a significant increase in the secretion of IL-6, IL-8 and MMP-3 (p < 0.01). Cartilage explants cultured with sEV from SF (± IL-1β) had a significant increase in the release of sGAG (p < 0.01). miRNA signatures differed between parental SF cells and isolated sEV. The recently identified osteoclastogenic regulator miR182, along with miR4472-2, miR1302-3, miR6720, miR6087 and miR4532 were enriched in sEV compared to parental cells, p < 0.01. Signatures were similar in sEVs derived from non-stimulated or IL-1β stimulated SF.Conclusions: OA SF sEV regulate chondrocyte inflammatory and remodelling responses. OA SF sEV have unique signatures compared to parental cells which do not alter with IL-1β stimulation. This study provides insight into a novel regulatory mechanism within the OA joint which could inform future targeted therapy.
MeSH
DOI 10.1186/s13075-024-03398-3
PMID 39342381
原文・出典を見る →